The ability of granulocytes and mononuclear phagocytes to phagocytose and kill S.aureus and to generate superoxide anion (O-2) upon stimulation with opsonized bacteria was studied in five patients (ages 9 to 26 years) with type I Gaucher disease (GD). Before treatment was started, bacteria were ingested equally by phagocytic cells from patients and age-matched controls. The extent of killing of S.aureus and the release of O-2 by granulocytes over 60 min incubation were also equivalent for patients and controls. However, we found that killing of viable bacteria and release of O-2 by the patients' monocytes were significantly lower than in cells from controls (p < 0.05 for both). The magnitude of differences in killing and O-2 release between patients' cells and those from controls was even more profound with macrophages (p < 0.001 for both). Enzyme augmentation with macrophage-targeted glucocerebrosidase for 6 mo at doses from 7.5 to 10 U/kg/week resulted in significant increases of functional activities and O-2 generation of monocytes and macrophages (45±9% and 6±4% killing of bacteria by monocytes and macrophages, respectively, before treatment compared to 66±12% and 13±4% killing by the two cell types after treatment, respectively, n = 5) along with hepatosplenic and hematologic improvements. These data suggest that mononuclear phagocytes from Gaucher patients are defective in their ability to kill bacteria and to generate O-2 and that enzyme substitution improves functions of monocytes and macrophages in patients with GD which should make them more resistant to severe bacterial infection.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Maródi, L., Káposzta, R., Tóth, J. et al. MICROBICIDAL CAPACITY OF PHAGOCYTIC CELLS FROM PATIENTS WITH TYPE I GAUCHER DISEASE. 1057. Pediatr Res 39 (Suppl 4), 179 (1996). https://doi.org/10.1203/00006450-199604001-01079
Issue Date:
DOI: https://doi.org/10.1203/00006450-199604001-01079